Navigation Links
Neuro Kinetics & Military Researchers in Push To Improve Diagnosis & Treatment of Combat Brain Injuries
Date:10/29/2009

PITTSBURGH, Oct. 29 /PRNewswire/ -- With financial backing from a leading nonprofit supporter of military medical research, medical device manufacturer Neuro Kinetics, Inc. (www.neuro-kinetics.com) said today that it is collaborating with the U.S. Army Aeromedical Research Laboratory (USAARL) at Fort Rucker, Alabama, and three other military medical facilities in a comprehensive research project to improve early diagnosis and treatment of mild traumatic brain injuries (mTBI).

The coordinated research focuses on using Neuro Kinetics' I-Portal® NOTC (Neuro-Otologic Test Center) system to evaluate and characterize vestibular, auditory and oculomotor conditions in soldiers suffering from hard-to-detect mTBI as a result of blast exposure. An estimated 20 percent of soldiers returning from Afghanistan and Iraq suffer from mTBI.

The other military medical facilities in the research project are Tripler Army Medical Center (Hawaii), The Traumatic Brain Injury Warrior Resilience and Recovery Center at Fort Campbell (Kentucky) and Walter Reed Army Medical Center (D.C.).

The military researchers' purchase of NKI's I-Portal NOTC system was supported in part by grants from the T.R.U.E. Research Foundation (www.trueresearch.org), a 501(c)(3) nonprofit corporation that assists the military medical community.

The project is expected to run until July 2010.

"It is our honor to be working closely with military researchers on this critically important effort," said J. Howison Schroeder, NKI president and CEO. "Research suggests that the oculometric measurements included in the I-Portal NOTC's battery of tests can provide effective neuro-physiologic and vestibular-auditory evaluations for mTBI, and that in turn can improve early screening and treatment.

"Our wounded soldiers deserve the best care possible and we are proud to be playing our part to deliver exactly that."

The NKI-military collaboration comes as a number of U.S. military facilities have installed the I-Portal NOTC system to improve diagnosis and monitoring of returning brain-injured military personnel. Numerous other federal government medical facilities, including those operated by the Veterans Administration and the National Institutes of Health, also rely on NKI equipment for conducting daily clinical evaluations of patients as well as undertaking a wide range of research projects.

ABOUT NEURO KINETICS, INC.

Neuro Kinetics, Inc. (www.neuro-kinetics.com) is a fast-growing manufacturer of noninvasive medical test equipment used worldwide by audiologists, neurologists, neuro-otologists, ophthalmologists, otolaryngologists and other medical specialists in the detection and evaluation of neurological, otological and vestibular disorders. The privately owned company, originating in the 1970s, pioneered the development of vestibular and neuro-otologic testing equipment, including the renowned Barany (rotational) chair. The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center) system, I-Portal® VNG (Video Nystagmography) system and I-Portal® VOG (Video Oculography) system, along with related accessories, software, training and support services. Users include doctors and researchers in universities and government facilities as well as specialists in fields such as audiology, neurology, neuro-otology, ophthalmology and otolaryngology.

    MEDIA CONTACT

    John Buckman
    Buckman Communications, for Neuro Kinetics, Inc.
    + 1 412-381-2900 or jbuckman@buckman.biz

SOURCE Neuro Kinetics, Inc.


'/>"/>
SOURCE Neuro Kinetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences Reports Third Quarter 2009 Results
2. Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
4. Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org
5. After a Stroke, When Seconds Count, Innovative Device from NeuroInterventions Speedily Restores Brains Blood Flow
6. NeurogesX to Present at JMP Securities Healthcare Focus Conference
7. BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury
8. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
9. Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment
10. Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression
11. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 23, 2017 Report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2015 through 2022. Also, a ... and analytics are derived from primary and secondary research. Company ...
(Date:2/24/2017)... , Feb. 23, 2017  This report analyzes ... by the following Products: Intermediates, Analytical, ... the report include Pharmaceuticals, and Agrochemicals. The report provides ... , Europe , and Rest ... the period 2015 through 2022. Also, a six-year historic ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... ... tooth replacement options at his office, Antoine Dental Center. Currently, patients can get ... Some restrictions may apply, but patients can learn more about these offers by ...
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... NY (PRWEB) , ... February 24, 2017 , ... In ... needs to be a top priority because it’s not if you will be attacked, ... safety, especially when it comes to digital health care. , Improvements in auditing and ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: An Australian ... account of his paramedic experiences. Schanssema describes the tragedies he saw, as well as ... overcome them. , Schanssema, initially unsure of the career path he wanted to take, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
Breaking Medicine News(10 mins):